Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus
Lists
Only you see this
Abstract
• Tilorone dihydrochloride possesses robust anti-SFTSV activity in vitro and in vivo. • Intraperitoneal administration of tilorone leads to protection against intracranial lethal challenge of SFTSV. • The anti-SFTSV mechanism of tilorone is through stimulation of host innate immunity. • Pre-treatment with tilorone can prevent mice from lethal SFTSV challenge.
BibTeX
@inproceedings{yang2022tilorone,
author = {Jing‐Jing Yang and Yunzheng Yan and Qingsong Dai and Ji‐Ye Yin and Lei Zhao and Yuexiang Li and Wei Li and Wu Zhong and Ruiyuan Cao and Song Li},
title = {{Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus}},
booktitle = {Virologica},
year = {2022},
doi = {10.1016/j.virs.2022.01.014},
}Loading related content...